Details of the Drug

General Information of Drug (ID: DM16I0A)

Drug Name

MBL949

Indication

Disease Entry	ICD 11	Status	REF
Obesity	5B81	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05199090) A Randomized, Placebo-controlled, Participant-and-investigator- Blinded, Sponsor Open-label Study to Evaluate the Safety, Tolerability, and Efficacy With Different Dosing Regimens of Subcutaneously Administered MBL949 in Obese Participants With or Without Type 2 Diabetes Mellitus. U.S.National Institutes of Health.